#Clinical Safety Boundary Statement: United Arab Emirates

DIS-GL-028 is the clinical safety boundary. It is the same boundary in every market, because it is a property of the product and not of the regulator. This document is the UAE fork and adds only the local regulatory frame and the local evidence position. It does not restate the feature boundary: read DIS-GL-028 Section 7 for that, and treat it as governing.

---

#Applicability

Applies to DM-1, DM-2, DM-3 and DM-4 identically. The regulatory character of software does not change with where it is hosted.

---

#Purpose

To state Pensieve Labs's medical-device position in the United Arab Emirates: what the local framework is, why Pensieve does not engage it, what evidence Pensieve Labs can put in front of a reviewer, and, precisely, what Pensieve Labs has not obtained.

---

#1. The position

Pensieve is an administrative and record-management platform. It is not marketed, labelled or supplied as a medical device in the United Arab Emirates. It performs no diagnostic, monitoring, scoring, alarm or treatment-recommendation function, in the United Arab Emirates or anywhere else.

Edsol Edtech Pvt. Ltd. holds no United Arab Emirates medical-device registration and requires none on the analysis below. It holds no ISO 13485 certification and no IEC 62304 conformity declaration, and seeks neither, because those are the quality-system standards for medical device manufacture.

---

#2. The local frame

Software as a medical device is regulated in the United Arab Emirates. The registration pathway runs through the Ministry of Health and Prevention, involving classification of the device by risk, submission of a technical documentation set, and approval before placing on the market.

[UNVERIFIED] The exact governing instrument was not resolved in the research behind this document. Federal legislation on medical products, the pharmacy profession and pharmaceutical establishments is the likely base, with subsequent transitional arrangements referenced but not pinned. Pensieve Labs will not cite a specific article or decision number to a customer until it has been confirmed from source.

Two observations that matter more than the missing citation:

1. The available material concentrates on physical devices. No source identified in the research indicates that a hospital information system, an electronic medical record or a hospital operating system, as such, requires medical-device registration in the United Arab Emirates.
2. The framework is broadly aligned with the international harmonisation model and with the European approach. That alignment is what makes Section 3 usable.

---

#3. The evidence Pensieve Labs puts forward

Pensieve Labs does not commission a separate United Arab Emirates regulatory analysis, and says why rather than leaving the omission to be noticed.

What Pensieve Labs has not obtained, stated as a gap:

Edsol Edtech Pvt. Ltd. has not obtained a formal classification opinion from a United Arab Emirates health authority, and does not represent that any authority has confirmed its position. A Customer that requires a local classification opinion should raise it at qualification. Pensieve Labs will support the application with the technical file and the qualification memorandum, and will bear its own costs of doing so. It will not assert a position it has not obtained.

---

#4. What would change the answer

The line is the same as in every other market, and DIS-GL-028 Section 1 states the principle: the moment software produces an output that a clinician is expected to act on as a clinical judgement, it stops being a record system. In this market, three specific things would trigger a fresh analysis and, on a positive result, a registration application before release:

1. Any module that interprets, scores, triages or recommends: early-warning scores, sepsis alerting, dosing calculation, image or trace interpretation, differential suggestion.
2. Any alarm or notification whose absence could cause harm. A notification that a task is overdue is administrative. A notification that a patient's condition has deteriorated is not.
3. Any claim in marketing, labelling, a proposal or a demonstration script that attributes clinical purpose to the Platform. Regulatory character follows the intended purpose the manufacturer states, and in this market as in every other, the fastest way to become a medical device is to say you are one. DIS-GL-028 Section 8 is the language control that prevents it, and it binds every UAE-facing document, proposal and demonstration.

Nothing in this list is on the roadmap for release in this market without the analysis being redone first. If it changes, this document changes with it and the change history records it.

---

#5. What is not a clinical safety question in this market, and is often confused with one

These are separated because a UAE reviewer will sometimes present them as one bundle, and answering them as one bundle produces a wrong answer to at least three of them.

---

#6. The shared boundary: what the hospital retains

Unchanged from DIS-GL-028 Section 9 and restated only in summary: clinical decisions are made by the Customer's licensed clinicians on their own professional judgement; the Customer is responsible for clinical governance, for the configuration of clinical content, for training, and for the safety case for its own use of the Platform. Pensieve Labs supplies a record system and supports it. It does not practise medicine, and no document, proposal or demonstration in this market may suggest otherwise.

Clause 14 of MSA-IN-001, as applied by MSA-AE-001 Section 9, is the contractual expression of this boundary.

---

#7. Limitations

7.1 The governing instrument is unconfirmed. Section 2. This is the most significant limitation in this document and it is stated first rather than last.

7.2 No local classification opinion is held. Section 3.

7.3 The analysis relied on is imported. It is a European qualification analysis applied to an aligned framework. It is well reasoned and it is not a local determination, and a Customer is entitled to weigh it as such.

7.4 The position is only as good as the product staying inside the boundary. Section 4 is a live control, not a historical statement.

---

#8. Related documents

---

#9. Change history

---